Follow us on Twitter
twitter icon@FreshPatents


Histocompatibility patents

      

This page is updated frequently with new Histocompatibility-related patent applications.




 Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers patent thumbnailNovel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh


 Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers patent thumbnailNovel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh


 Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers patent thumbnailNovel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh


 Method for identifying novel minor histocompatibility antigens patent thumbnailMethod for identifying novel minor histocompatibility antigens
A novel method for human minor histocompatibility antigen (miha) discovery, novel mihas identified using this method, as well as uses of the novel mihas, are described. One of the features of the novel method is the inclusion of personalized translated transcriptome and/or exome in the database used for peptide identification by mass spectroscopy (ms).
UniversitÉ De MontrÉal


 Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers patent thumbnailNovel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh


 Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers patent thumbnailNovel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh


 Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers patent thumbnailNovel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh


 Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers patent thumbnailNovel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh


 Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers patent thumbnailNovel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh


 Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers patent thumbnailNovel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh


Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh

Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh

Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh

Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh

Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnology Gmbh

Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh

Novel peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh

Peptide sequences and compositions

Wherein, the polypeptide is immunogenic in a vertebrate expressing a major histocompatibility complex (mhc) allele, and wherein the polypeptide is not a complete influenza virus protein.. .

Therapeutic and diagnostic cloned mhc-unrestricted receptor specific for the muc1 tumor associated antigen

The invention provides an isolated nucleic acid encoding a receptor, other than an immunoglobulin, wherein the receptor binds to a muc1 tumor antigen independently of an major histocompatibility complex (mhc). The invention provides a method of activating a signaling pathway and/or killing a cancer cell using a receptor that is similar to or is a t cell receptor.
University Of Pittsburgh - Of The Commonwealth System Of Higher Education

Novel cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer, in particular myeloma.
Immatics Biotechnologies Gmbh

Method for generating t-cells compatible for allogenic transplantation

The present invention pertains to engineered t-cells, method for their preparation and their use as medicament, particularly for immunotherapy. The engineered t-cells of the invention are characterized in that the expression of beta 2-microglobulin (b2m) and/or class ii major histocompatibility complex transactivator (ciita) is inhibited, e.g., by using rare-cutting endonucleases able to selectively inactivating by dna cleavage the gene encoding b2m and/or ciita, or by using nucleic acid molecules which inhibit the expression of b2m and/or ciita.
Cellectis

Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh

Soluble mic neutralizing monoclonal antibody for treating cancer

Disclosed are compositions and methods relating to antibodies that bind soluble major histocompatibility complex class i chain-related (smic). Specifically, disclosed are antibodies designed or selected to inhibit smic (e.g.
University Of Washington Through Its Center For Commercialization

Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh

Methods of treating and preventing minor histocompatibility antigen-mismatched grafts

Disclosed herein are methods of preventing and/or reducing minor histocompatibility antigen-mismatched grafts by depletion and/or inhibition of basic leucine zipper transcription factor atf-like 3 (batf3)-dependent antigen-presenting cells.. .
National Jewish Health

Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh

Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer.
Immatics Biotechnologies Gmbh

Method for treating cancer

The present invention provides a method for treating or alleviating a symptom of a disorder, e.g., immune evasion, cancer-cell induced immune dysfunction, reduced immune response, lowered inflammation, decreased expression of a major histocompatibility complex (mhc), or cancer, characterized by aberrant, misregulated, or increased enhancer of zeste homolog 2 (ezh2) activity in a cell or subject in need thereof by contacting the cell or administering to the subject a therapeutically effective amount of an ezh2 inhibitor.. .
Epizyme, Inc.



Histocompatibility topics:
  • Histocompatibility
  • Compatibility
  • Major Histocompatibility Complex
  • Immune Response
  • Specificity
  • Antibodies
  • Recombinant
  • Polypeptide
  • Stimulator
  • Immunostimulator
  • Therapeutics
  • Monoclonal Antibody
  • Immunotherapy
  • Monoclonal
  • Nucleic Acid


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Histocompatibility for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Histocompatibility with additional patents listed. Browse our RSS directory or Search for other possible listings.


    2.1098

    file did exist - 3277

    1 - 1 - 54